IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 98 filers reported holding IGM BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $568,122 | -21.4% | 41,348 | -2.7% | 0.00% | -100.0% |
| Q4 2022 | $723,197 | -21.7% | 42,516 | +4.6% | 0.00% | 0.0% |
| Q3 2022 | $924,000 | +32.4% | 40,633 | +4.9% | 0.00% | 0.0% |
| Q2 2022 | $698,000 | -34.8% | 38,733 | -3.3% | 0.00% | 0.0% |
| Q1 2022 | $1,071,000 | +73.9% | 40,067 | +90.8% | 0.00% | – |
| Q4 2021 | $616,000 | -54.2% | 21,000 | +2.6% | 0.00% | -100.0% |
| Q3 2021 | $1,346,000 | -20.8% | 20,467 | +0.2% | 0.00% | -50.0% |
| Q2 2021 | $1,700,000 | +8.8% | 20,428 | +0.2% | 0.00% | 0.0% |
| Q1 2021 | $1,563,000 | -14.5% | 20,378 | -1.6% | 0.00% | 0.0% |
| Q4 2020 | $1,829,000 | -20.2% | 20,713 | -33.3% | 0.00% | -33.3% |
| Q3 2020 | $2,292,000 | +0.3% | 31,052 | -0.8% | 0.00% | 0.0% |
| Q2 2020 | $2,285,000 | +30.0% | 31,302 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $1,758,000 | +41.3% | 31,302 | -4.0% | 0.00% | +50.0% |
| Q4 2019 | $1,244,000 | – | 32,606 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |